Literature DB >> 16782236

Synthesis and SAR study of acridine, 2-methylquinoline and 2-phenylquinazoline analogues as anti-prion agents.

H Cope1, R Mutter, W Heal, C Pascoe, P Brown, S Pratt, B Chen.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are thought to arise from aggregation of a protease resistant protein denoted PrP(Sc), which is a misfolded isoform of the normal cellular prion protein PrP(C). Using virtual high-throughput screening we have selected structures analogous to acridine, 2-methyquinoline and 2-phenylquinazoline as potential therapeutic candidates for the treatment of TSEs. From the synthesis and screening of constructed libraries we have shown that an electron-rich aromatic ring attached through an amine linker to the position para to the ring nitrogen is beneficial to both binding to PrP(C) and the suppression of PrP(Sc) accumulation for acridine and 2-methylquinoline analogues. 2-Phenylquinazoline analogues appear to utilise a different mode of action by binding at a different location and/or pose. We report IC50s in the nanomolar range.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782236     DOI: 10.1016/j.ejmech.2006.05.002

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Prediction of antiprion activity of therapeutic agents with structure-activity models.

Authors:  Katja Venko; Špela Župerl; Marjana Novič
Journal:  Mol Divers       Date:  2013-09-20       Impact factor: 2.943

2.  Prion protein-coated magnetic beads: synthesis, characterization and development of a new ligands screening method.

Authors:  Marcela Cristina de Moraes; Juliana Bosco Santos; Daniel Meira Dos Anjos; Luciana Pereira Rangel; Tuane Cristine Ramos Gonçalves Vieira; Ruin Moaddel; Jerson Lima da Silva
Journal:  J Chromatogr A       Date:  2014-12-12       Impact factor: 4.759

3.  Design, synthesis, and biological evaluation of AV6 derivatives as novel dual reactivators of latent HIV-1.

Authors:  Mingtao Ao; Zhenrui Pan; Yuqing Qian; Bowen Tang; Zeming Feng; Hua Fang; Zhen Wu; Jingwei Chen; Yuhua Xue; Meijuan Fang
Journal:  RSC Adv       Date:  2018-05-11       Impact factor: 4.036

Review 4.  Pharmacological Agents Targeting the Cellular Prion Protein.

Authors:  Maria Letizia Barreca; Nunzio Iraci; Silvia Biggi; Violetta Cecchetti; Emiliano Biasini
Journal:  Pathogens       Date:  2018-03-07

Review 5.  Exploring Anti-Prion Glyco-Based and Aromatic Scaffolds: A Chemical Strategy for the Quality of Life.

Authors:  María Teresa Blázquez-Sánchez; Ana M de Matos; Amélia P Rauter
Journal:  Molecules       Date:  2017-05-24       Impact factor: 4.411

6.  Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death.

Authors:  Senyi Benti; Purushottam B Tiwari; Dustin W Goodlett; Leily Daneshian; Grant B Kern; Mark D Smith; Aykut Uren; Maksymilian Chruszcz; Linda S Shimizu; Geeta Upadhyay
Journal:  Cancers (Basel)       Date:  2020-02-22       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.